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The role of uncoupling protein 3
in human physiology
W. Timothy Garvey
Division of Endocrinology, Diabetes, and Medical Genetics and Department of Medicine,
Medical University of South Carolina, and Ralph H. Johnson Veterans Affairs Medical Center,
Charleston, South Carolina, USA

J. Clin. Invest. 111:438–441 (2003). doi:10.1172/JCI200317835.

Obesity is simply understood as an
imbalance between energy intake and
expenditure in favor of weight accretion. However, the human biological
interface between food consumption
and energy dissipation results in
broad individual differences in eating
behavior, physical activity, and efficiency of fuel storage and metabolism.
In particular, the basal metabolic rate,
which accounts for the greatest portion of overall energy expenditure, can
vary almost twofold among individuals. Classically, three major biochemical systems are believed to contribute
to basal thermogenesis: futile cycles,
Na+/K+ATPase activity, and mitochondrial proton leak. The latter is
the most important quantitative contributor and can explain up to 50% of
the basal metabolic rate (1). The
molecular basis of mitochondrial proton leak is unclear, despite its importance in the understanding of energy
balance and its potential as a therapeutic target for obesity treatment.
The article by Hesselink and colleagues in this issue of the JCI (2)
addresses whether uncoupling protein 3 contributes to mitochondrial
proton leak in human skeletal muscle.
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Mitochondrial respiration
and oxidative phosphorylation
The oxidation of fatty acids and pyruvate takes place in mitochondria,
where energy is converted into ATP
for use in cellular processes. Reducing
equivalents are extracted from substrates and sequentially passed from
electron donors (reductants) to acceptors (oxidants) along the mitochondrial respiratory chain to molecular oxygen. The electron transport system is
located on the inner mitochondrial
membrane, where oxidation steps are
coupled by the transport chain to the
extrusion of protons out of the
matrix. This establishes an electrochemical potential difference across
the inner membrane and a motive
force for proton reentry through
F1F0-ATP synthase. ATP synthase captures the potential energy released
upon proton reentry by converting
ADP to ATP. In this manner, electron
transport is coupled to oxidative
phosphorylation. In a perfectly coupled system, protons only enter the
mitochondrial matrix through ATP
synthase in the presence of ADP; this
form of respiration is classified as
state 3 (i.e., O2 is consumed only in
the presence of substrate and ADP).
However, mitochondria can also be
observed to use oxygen even in the
absence of ADP, which occurs when
protons leak back into the matrix via
a mechanism that does not involve
F1F0-ATPase. This proton leak reduces
the proton gradient driving ATP formation and uncouples respiration
from oxidative phosphorylation. Oxygen utilization in the absence of ADP
or in totally uncoupled mitochondria
is referred to as state 4 respiration.
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Uncoupling proteins
The mechanisms mediating ATPaseindependent proton leak have not
been identified, except in mammalian
brown adipose tissue (BAT). BAT is
rich in mitochondria and lipid
droplets and is a major source of nonshivering thermogenesis, used by most
mammals to resist cold. This function
is mediated by uncoupling protein 1
(UCP1) (previously known as uncoupling protein or thermogenin), first
cloned in 1985 (3). UCP1 localizes to
the mitochondrial inner membrane
and dissipates the transmembrane
potential by transporting protons
from the intermembrane space back
into the matrix. This reduces the proton motive force that drives ATP formation, and respiration in the uncoupled mitochondria proceeds, releasing
fuel energy only as heat. In humans
and other large mammals, BAT disappears after infancy, and there is minimal or no detectable UCP1 expression
in adults. However, even in the absence
of UCP1, there is a finite proton leak
across the inner membrane that cannot be explained by simple diffusion
(4). This led investigators to search for
additional uncoupling proteins with
broader tissue expression, and two
other members of the uncoupling protein family were identified in 1997.
The genes encoding human UCP2 (5,
6) and UCP3 (7, 8) lie in close proximity to each other on chromosome
11q13 and share 55% and 57% amino
acid identity with UCP1, respectively.
UCP2 mRNA is widely expressed in
multiple tissues, while UCP3 exhibits
more limited tissue-specific expression
confined to skeletal muscle and brown
fat tissue. UCPs have similar predicted
topology consisting of six transmembrane regions linked by polar loops
and are localized to the inner mitochondrial membrane. More recently,
two additional UCP-like genes, UCP4
and UCP5/brain mitochondrial carrier protein–1, have been identified,
which are expressed in the brain and
have relatively lower amino acid identity with UCP1 (30–40%).
Because of their homology with UCP1
and expression in adult tissues, UCP2
and UCP3 immediately were considered
as attractive candidates for proteins
involved in energy expenditure. When
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increase in the ATP/ADP ratio, and a
decrease in state 4 respiration, consistent with an uncoupling effect for UCP3
when present in the wild-type mice.
Transgenic mice hyperexpressing UCP3
were characterized by reduced body
weight, despite being hyperphagic, by
increased resting O2 consumption, and
by increased muscle temperature but
not core temperature. At the same time,
isolated mitochondria exhibited decreased transmembrane potential and
increased state 4 respiration. These
results in transgenic mice were more
consistent with a role for UCP3 as a
mitochondrial uncoupler.

Figure 1
Uncoupling proteins and mitochondrial function. The figure shows key proteins in the inner mitochondrial membrane involved in mitochondrial respiration, oxidative phosphorylation, uncoupling,
and import of long-chain acyl-CoA molecules. Two potential roles for UCP3 function are illustrated. (right-hand side) UCP3 functions as an uncoupler by acting as a channel for proton entry into
the matrix, which dissipates the transmembrane potential generated by respiratory chain complexes I through IV. This reduces the motive force for proton entry via the F1F0-ATPase, which catalyzes
ATP synthesis, and, in effect, uncouples respiration from oxidative phosphorylation. Substrate oxidation proceeds via transfer of electrons from donors (reductants) to acceptors (oxidants) along
the respiratory chain to water, releasing energy as heat. Another consequence is a reduction in reactive oxygen species formation, since these species are generated under conditions of high transmembrane potential and electron flow. (left-hand side) In another scenario, UCP3 acts as an
exporter of fatty acid anions (FA-). This could facilitate fatty acid oxidation and explain experimental observations linking regulation of UCP3 expression and genetic variation with effects on fat oxidation. Under conditions of high fatty acid flux into mitochondria via carnitine palmitoyltransferase
1 (CPT1), excessive accumulation of long chain acyl-CoA molecules would be harmful to membranes and sequester CoA, thereby impairing fat oxidation. To prevent these events, upregulation
of mitochondrial thioesterase cleaves the acyl-CoA allowing export of the fatty acid anion via UCP3.
Reuptake of a neutral fatty acid could deliver the proton (plus fatty acid anion) back into the matrix
resulting in uncoupling; however, the fatty acid export function would not necessarily depend upon
an uncoupling action for UCP3. e-, electron; I, Complex I or NADH-ubiquinone oxidoreductase; II,
Complex II or succinate ubiquinone oxidoreductase; III, Complex III or ubiquinol-cytochrome c oxidoreductase; IV, Complex IV or cytochrome c oxidase; Q, coenzyme Q or ubiquinone; c, cytochrome
c; UQ•–, ubisemiquinone; O2•–, superoxide; ROS, reactive oxygen species; SOD, superoxide dismutase; F1 is the water-soluble nucleotide-binding complex and F0 is the hydrophobic transmembrane
complex that together comprise the F1F0-ATPase.

expressed in yeast and mammalian cell
lines, both UCP2 and UCP3, like UCP1,
were shown to act as uncouplers, as evidenced by a decrease in mitochondrial
membrane potential and increases in
mitochondrial state 4 respiration, whole
cell O2 consumption, and heat production. In addition, UCP1, UCP2, and
UPC3 shared in common the ability to
be regulated by factors important in
energy balance including β3-adrenoreceptor agonists, triiodothyronine, food
intake, and cold exposure (although
cold exerted more modest effects on
UCP2 and UCP3 than on UCP1). However, the paradigm began to unravel
2

when results from whole animal experimentation were considered. First, both
fasting and high-fat feeding in rodents
were found to upregulate UCP2 and
UCP3, even though the former caused a
decrease in energy expenditure and the
latter had the opposite effect (3). Second, UCP2 and UCP3 knock-out mice
exhibited normal body weight when
consuming conventional or high-fat
chow, as well as normal body temperature at room temperature and in
response to cold (9, 10). Paradoxically,
mitochondria isolated from the skeletal
muscle of UCP3 null mice were found
to have a reduced proton leak, an
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Importance of human studies
Hesselink et al. (2) have studied the
capacity of UCP3 to act as an uncoupler in human skeletal muscle following a diet-induced increase in
UCP3 expression. Healthy male volunteers expressed 44% more UCP3
protein in skeletal muscle while consuming a high-fat diet than while
consuming a low-fat diet. The investigators assessed mitochondrial function in vivo by measuring phosphocreatine resynthesis following anoxic
muscle contractions. To permit rapid
bursts of muscle contraction, highenergy phosphate bonds are stored as
phosphocreatine, which is formed by
transfer of phosphate from ATP to
creatine catalyzed by creatine kinase.
The rate of phosphocreatine resynthesis reflects ATP synthetic rates via
mitochondrial F1F0-ATPase, which in
turn is affected by the extent of mitochondrial uncoupling. The authors
observed similar time courses of
phosphocreatine repletion in the
high-fat and low-fat fed subgroups,
indicating that the physiological
upregulation of UCP3 with high-fat
feeding did not affect the mitochondrial proton leak in vivo. The authors
also found that relative amounts of
free carnitine and acylcarnitine were
similar in both subgroups, verifying
that there were no differences in substrate availability (at least from longchain fatty acids). The authors were
able to reject their initial hypothesis
and conclude that UCP 3 does not act
as a mitochondrial uncoupler in
human muscle under these physiological conditions.
The paper is instructive for several
reasons. First, the authors have quantified UCP3 expression at the protein
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level using well-characterized and specific affinity-purified antibodies. The
literature to date has relied heavily on
measurements of mRNA to study
UCP2 and UCP3 expression, since
available antibodies have lacked specificity. Second, the authors have
assessed mitochondrial uncoupling in
vivo following a diet-induced physiological perturbation of UCP3 levels. In
knock-out mice, evidence that UCP2
or UCP3 functions as an uncoupler
has derived from experiments performed in isolated mitochondria ex
vivo, not in intact tissues. The lack of
effects on energy metabolism and
body weight in these mice would suggest that the uncoupling in isolated
mitochondria either does not occur in
vivo or is not physiologically significant. In addition, Brand and his colleagues have recently found that
uncoupling in the presence of supraphysiological UCP3 hyperexpression,
at the high levels obtained in transfected yeast and in UCP3 transgenic
mice, was induced by artifact and did
not represent properties of the native
protein (11). This observation makes it
difficult to derive meaningful physiological information from the study of
the transgenic mice (12), which hyperexpressed UCP3 more than 50-fold
above the level in wild-type mice (11).
The emerging picture is that accurate
physiological information can most
confidently be obtained when mitochondrial uncoupling is assessed in
vivo within the physiological range of
UCP regulation.
Third, the authors studied human
beings. While transgenic mice experiments have been highly prized by firstline biomedical journals, experiments
involving human physiology have
been relatively undervalued in my
opinion. Particularly in the area of
energy expenditure, it is problematic
to extrapolate data in transgenic mice
to human physiology since adult
humans do not have brown fat and
heat production per kg body weight is
much lower in humans than in
rodents. This lesson was learned in the
case of leptin, which exerts major
effects on body temperature in
rodents, while this physiological
action is markedly attenuated or lacking in humans (13, 14). The observations of Hesselink et al. (2) are not only
directly relevant to human physiology,
but constitute some of the strongest

data in any system addressing the
basic biochemical role of UCP3 as an
uncoupler. On balance, the paper
seems to prove the old adage that, if
you want to understand human physiology, sometimes you just have to
study humans.
There are also limitations to data
interpretation. The authors cannot
exclude the possibility that the dietary
perturbations induced some other factor that modulates an uncoupling
effect of UCP3 or that an uncoupling
effect was too weak to discern using
this methodology, despite evidence
marshaled by the authors that phosphocreatine repletion rate is sensitive
to mitochondrial substrate availability.
The authors also point out that UCP3
upregulation could have been counterbalanced by UCP2 downregulation (or
that of other unidentified uncouplers)
resulting in no net change in the mitochondrial proton leak. The authors discount this possibility for two reasons;
UCP2 mRNA levels were unchanged,
and other authors have provided
immunological evidence that UCP2
protein is not expressed in muscle
despite the presence of UCP2 mRNA
(15). Even so, these latter observations
were reported in rodent muscle, leaving
open the possibility that UCP2 protein
is present in human muscle.

What is the role of UCPs?
If the authors’ conclusions are correct,
then what is the biochemical role of
UCP3 in humans? This question
remains an intriguing and important
issue for future research. Several investigators support the idea that UCP2
and UCP3 play a role in reducing reactive oxygen species formation and so
protect cells from their damaging
effects (16). Reactive oxygen species are
produced in the course of mitochondrial respiration in a manner that is proportional to the transmembrane
potential; therefore, this role would
require that UCP3 function as an
uncoupler. Another exciting hypothesis is that UCP3 could facilitate lipid
oxidation by acting as an FFA anion
transporter. Elevated circulating FFA
levels are associated with increased
muscle UCP3 expression in a variety of
physiological states (fasting, high-fat
feeding, lipid infusion, diabetes, obesity) independent of any changes in energy expenditure (3, 17, 18). In addition,
we have described an exon 6 splice
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donor/acceptor polymorphism in
UCP3 that is associated with a marked
reduction in basal lipid oxidation rates
and an increase in resting respiratory
quotient in Gullah-speaking African
Americans (19). It is difficult to explain
how an FFA anion transporter could
facilitate FFA oxidation since entry of
long-chain FFA through carnitine
palmitoyltransferase I and subsequent
oxidation requires esterification to
CoA. However, under conditions of
high acyl-CoA flux and lipid oxidation, accumulation of acyl-CoA would
be detrimental to mitochondrial function since these molecules are strong
surfactants that could damage membranes and excessive sequestration of
CoA in the form of long chain FFA
esters could inhibit β-oxidation and tricarboxylic acid cycle activity. UCPs are
known to be able to export FFA anion
from the mitochondrial matrix (20),
but this could only help alleviate the
accumulation of acyl-CoA if a
thioesterase were available to remove
CoA from the FFA. Recently, Moore et
al. have shown that mitochondrial
thioesterase-1 is upregulated in UCP3hyperexpressing mice and have proposed that this enzyme could perform
this very function in settings of
increased acyl-CoA flux (21). Thus, it is
feasible to suggest that UCP3 could
help sustain increased rates of lipid
oxidation via export of FFA anion. In
any event, as the search for the true
physiological role of UCP3 continues,
confident conclusions regarding
human physiology will require studies
in humans.
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